GLP1R and obesity disorder: Finally, further high-throughput investigations to evaluate all other key residues involved in GLP-1R-cholesterol binding will generate high value data for the future development of novel GLP-1R allosteric modulators with improved signalling properties for the treatment of T2D and obesity.